Clinical Trials
3 trialsNCT06105008 2024-08-23
Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer
RemeGen Co., Ltd.
Phase 2 Withdrawn
NCT05212922 2023-03-20
YH001
Eucure (Beijing) Biopharma Co., Ltd
Phase 2 Withdrawn
NCT05165849 2022-05-20
A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2 Withdrawn